UniSuper Management Pty Ltd Has $33.90 Million Stock Holdings in HCA Healthcare, Inc. $HCA

UniSuper Management Pty Ltd trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 4.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 72,621 shares of the company’s stock after selling 3,752 shares during the quarter. UniSuper Management Pty Ltd’s holdings in HCA Healthcare were worth $33,904,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Nordea Investment Management AB boosted its holdings in HCA Healthcare by 11.2% during the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after buying an additional 108,849 shares during the last quarter. Nomura Asset Management Co. Ltd. lifted its holdings in shares of HCA Healthcare by 6.2% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after purchasing an additional 3,724 shares in the last quarter. Hudson Bay Capital Management LP lifted its holdings in shares of HCA Healthcare by 154.5% during the 3rd quarter. Hudson Bay Capital Management LP now owns 4,693 shares of the company’s stock valued at $2,000,000 after purchasing an additional 2,849 shares in the last quarter. Advisors Capital Management LLC lifted its stake in HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after acquiring an additional 2,604 shares in the last quarter. Finally, CWA Asset Management Group LLC lifted its stake in HCA Healthcare by 1,062.4% in the 4th quarter. CWA Asset Management Group LLC now owns 9,555 shares of the company’s stock valued at $4,461,000 after acquiring an additional 8,733 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on HCA shares. JPMorgan Chase & Co. cut their target price on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 19th. KeyCorp lowered their price target on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Weiss Ratings lowered HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday. UBS Group boosted their price target on HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research report on Monday, February 23rd. Finally, Mizuho boosted their price target on HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $506.14.

HCA Healthcare Trading Up 1.2%

HCA stock opened at $377.81 on Friday. The firm has a market capitalization of $83.81 billion, a PE ratio of 12.99, a PEG ratio of 1.18 and a beta of 1.12. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The business’s 50 day simple moving average is $431.36 and its 200 day simple moving average is $474.09.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue was up 4.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.